<?xml version='1.0' encoding='UTF-8'?>
<search_results><query id="7404">kobe bryant</query><engine status="OK" timestamp="2014-04-23 02:09:10" name="PubMed" id="FW14-e017"/><snippets><snippet id="FW14-e017-7404-01"><link cache="FW14-topics-docs/e017/7404_01.html" timestamp="2014-04-23 02:09:11">http://www.ncbi.nlm.nih.gov/pubmed/18292371</link><title>Prevalence and effects of rape myths in print journalism: the Kobe Bryant case.</title><description>Franiuk R, Seefelt JL, Cepress SL, Vandello JA.

Violence Against Women. 2008 Mar;14(3):287-309. doi: 10.1177/1077801207313971.</description></snippet><snippet id="FW14-e017-7404-02"><link cache="FW14-topics-docs/e017/7404_02.html" timestamp="2014-04-23 02:10:29">http://www.ncbi.nlm.nih.gov/pubmed/18045209</link><title>Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationships.</title><description>Shiotani K, Miyazaki A, Li T, Tsuda Y, Yokoi T, Ambo A, Sasaki Y, Bryant SD, Jinsmaa Y, Lazarus LH, Okada Y.

Med Chem. 2007 Nov;3(6):583-98.</description></snippet><snippet id="FW14-e017-7404-03"><link cache="FW14-topics-docs/e017/7404_03.html" timestamp="2014-04-23 02:11:28">http://www.ncbi.nlm.nih.gov/pubmed/17826995</link><title>Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platform.</title><description>Shiotani K, Li T, Miyazaki A, Tsuda Y, Yokoi T, Ambo A, Sasaki Y, Bryant SD, Lazarus LH, Okada Y.

Bioorg Med Chem Lett. 2007 Nov 1;17(21):5768-71. Epub 2007 Aug 28.</description></snippet><snippet id="FW14-e017-7404-04"><link cache="FW14-topics-docs/e017/7404_04.html" timestamp="2014-04-23 02:13:03">http://www.ncbi.nlm.nih.gov/pubmed/17497839</link><title>Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.</title><description>Li T, Shiotani K, Miyazaki A, Tsuda Y, Ambo A, Sasaki Y, Jinsmaa Y, Marczak E, Bryant SD, Lazarus LH, Okada Y.

J Med Chem. 2007 Jun 14;50(12):2753-66. Epub 2007 May 12.</description></snippet><snippet id="FW14-e017-7404-05"><link cache="FW14-topics-docs/e017/7404_05.html" timestamp="2014-04-23 02:14:07">http://www.ncbi.nlm.nih.gov/pubmed/17142049</link><title>Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists.</title><description>Li T, Jinsmaa Y, Nedachi M, Miyazaki A, Tsuda Y, Ambo A, Sasaki Y, Bryant SD, Marczak E, Li Q, Swartzwelder HS, Lazarus LH, Okada Y.

Bioorg Med Chem. 2007 Feb 1;15(3):1237-51. Epub 2006 Nov 14.</description></snippet><snippet id="FW14-e017-7404-06"><link cache="FW14-topics-docs/e017/7404_06.html" timestamp="2014-04-23 02:15:39">http://www.ncbi.nlm.nih.gov/pubmed/16949282</link><title>Synthesis of 3,6-bis[H-Tyr/H-Dmt-NH(CH2)m,n]-2(1H)pyrazinone derivatives: function of alkyl chain length on opioid activity.</title><description>Shiotani K, Li T, Miyazaki A, Tsuda Y, Bryant SD, Ambo A, Sasaki Y, Lazarus LH, Okada Y.

Bioorg Med Chem Lett. 2006 Nov 15;16(22):5793-6. Epub 2006 Sep 1.</description></snippet><snippet id="FW14-e017-7404-07"><link cache="FW14-topics-docs/e017/7404_07.html" timestamp="2014-04-23 02:17:17">http://www.ncbi.nlm.nih.gov/pubmed/16335927</link><title>Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.</title><description>Li T, Fujita Y, Shiotani K, Miyazaki A, Tsuda Y, Ambo A, Sasaki Y, Jinsmaa Y, Marczak E, Bryant SD, Salvadori S, Lazarus LH, Okada Y.

J Med Chem. 2005 Dec 15;48(25):8035-44.</description></snippet><snippet id="FW14-e017-7404-08"><link cache="FW14-topics-docs/e017/7404_08.html" timestamp="2014-04-23 02:18:50">http://www.ncbi.nlm.nih.gov/pubmed/16183273</link><title>New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif.</title><description>Li T, Shiotani K, Miyazaki A, Fujita Y, Tsuda Y, Ambo A, Sasaki Y, Jinsmaa Y, Marczak E, Bryant SD, Lazarus LH, Okada Y.

Bioorg Med Chem Lett. 2005 Dec 15;15(24):5517-20. Epub 2005 Sep 23.</description></snippet><snippet id="FW14-e017-7404-09"><link cache="FW14-topics-docs/e017/7404_09.html" timestamp="2014-04-23 02:19:28">http://www.ncbi.nlm.nih.gov/pubmed/16141586</link><title>Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenation.</title><description>Miyazaki A, Fujisawa Y, Shiotani K, Fujita Y, Li T, Tsuda Y, Yokoi T, Bryant SD, Lazarus LH, Okada Y.

Chem Pharm Bull (Tokyo). 2005 Sep;53(9):1152-8.</description></snippet><snippet id="FW14-e017-7404-10"><link cache="FW14-topics-docs/e017/7404_10.html" timestamp="2014-04-23 02:21:24">http://www.ncbi.nlm.nih.gov/pubmed/15664820</link><title>Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3).</title><description>Fujita Y, Tsuda Y, Motoyama T, Li T, Miyazaki A, Yokoi T, Sasaki Y, Ambo A, Niizuma H, Jinsmaa Y, Bryant SD, Lazarus LH, Okada Y.

Bioorg Med Chem Lett. 2005 Feb 1;15(3):599-602.</description></snippet></snippets></search_results>